Showing codes C9057 (Injection, cetirizine hydrochloride, 1 mg) — C9087 (Injection, cyclophosphamide, (auromedics), 10 mg)

C9057 - Inj cetirizine hydrochloride
Long description: Injection, cetirizine hydrochloride, 1 mg
Code added date: 20200401.
Code effective date: 20200701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9058 - Injection,pegfilgrastim-bmez
Long description: Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mg
Code added date: 20191115.
Code effective date: 20200701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9059 - Injection, meloxicam
Long description: Injection, meloxicam, 1 mg
Code added date: 20200701.
Code effective date: 20201001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9060 - Fluoroestradiol f18
Long description: Fluoroestradiol f18, diagnostic, 1 mci
Code added date: 20201001.
Code effective date: 20210101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9061 - Injection, teprotumumab-trbw
Long description: Injection, teprotumumab-trbw, 10 mg
Code added date: 20200701.
Code effective date: 20201001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9062 - Daratumumab hyaluronidase
Long description: Injection, daratumumab 10 mg and hyaluronidase-fihj
Code added date: 20201001.
Code effective date: 20210101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9063 - Injection, eptinezumab-jjmr
Long description: Injection, eptinezumab-jjmr, 1 mg
Code added date: 20200701.
Code effective date: 20201001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9064 - Mitomycin pyelocalyceal inst
Long description: Mitomycin pyelocalyceal instillation, 1 mg
Code added date: 20201001.
Code effective date: 20210101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9065 - Romidepsin non-lyophilized
Long description: Injection, romidepsin, non-lyophilized (e.g. liquid), 1mg
Code added date: 20201001.
Code effective date: 20211001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9066 - Sacituzumab govitecan-hziy
Long description: Injection, sacituzumab govitecan-hziy, 2.5 mg
Code added date: 20201001.
Code effective date: 20210101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9067 - Gallium ga-68 dotatoc
Long description: Gallium ga-68, dotatoc, diagnostic, 0.01 mci
Code added date: 20201001.
Code effective date: 20240101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9068 - Copper cu-64, dotatate, dx
Long description: Copper cu-64, dotatate, diagnostic, 1 millicurie
Code added date: 20210101.
Code effective date: 20210401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9069 - Belantamab mafodontin-blmf
Long description: Injection, belantamab mafodontin-blmf, 0.5 mg
Code added date: 20210101.
Code effective date: 20210401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9070 - Injection, tafasitamab-cxix
Long description: Injection, tafasitamab-cxix, 2 mg
Code added date: 20210101.
Code effective date: 20210401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9071 - Injection, viltolarsen
Long description: Injection, viltolarsen, 10 mg
Code added date: 20210101.
Code effective date: 20210401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9072 - Inj, imm glob asceniv
Long description: Injection, immune globulin (asceniv), 500 mg
Code added date: 20210101.
Code effective date: 20210401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9073 - Brexucabtagene autoleucel ca
Long description: Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20210101.
Code effective date: 20210401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9074 - Injection, lumasiran
Long description: Injection, lumasiran, 0.5 mg
Code added date: 20210401.
Code effective date: 20210701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9075 - Injection, casimersen, 10 mg
Long description: Injection, casimersen, 10 mg
Code added date: 20210701.
Code effective date: 20211001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9076 - Lisocabtagene car pos t
Long description: Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20210701.
Code effective date: 20211001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9077 - Inj cabotegravir/rilpivirine
Long description: Injection, cabotegravir and rilpivirine, 2mg/3mg
Code added date: 20210701.
Code effective date: 20211001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9078 - Inj, trilaciclib, 1 mg
Long description: Injection, trilaciclib, 1 mg
Code added date: 20210701.
Code effective date: 20211001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9079 - Inj, evinacumab-dgnb, 5 mg
Long description: Injection, evinacumab-dgnb, 5 mg
Code added date: 20210701.
Code effective date: 20211001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9080 - Inj, melphalan flufen, 1 mg
Long description: Injection, melphalan flufenamide hydrochloride, 1 mg
Code added date: 20210701.
Code effective date: 20211001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9081 - Idecabtagene car pos t
Long description: Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20211001.
Code effective date: 20220101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9082 - Inj dostarlimab-gxly, 100 mg
Long description: Injection, dostarlimab-gxly, 100 mg
Code added date: 20211001.
Code effective date: 20220101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9083 - Inj, amivantamab-vmjw, 10 mg
Long description: Injection, amivantamab-vmjw, 10 mg
Code added date: 20211001.
Code effective date: 20220101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9084 - Loncastuximab-lpyl, 0.1 mg
Long description: Injection, loncastuximab tesirine-lpyl, 0.1 mg
Code added date: 20211001.
Code effective date: 20220401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9085 - Inj avalglucosid alfa-ngpt
Long description: Injection, avalglucosidase alfa-ngpt, 4 mg
Code added date: 20220101.
Code effective date: 20220401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9086 - Inj, anifrolumab-fnia
Long description: Injection, anifrolumab-fnia, 1 mg
Code added date: 20220101.
Code effective date: 20220401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9087 - Inj cyclophosphamd auromedic
Long description: Injection, cyclophosphamide, (auromedics), 10 mg
Code added date: 20220101.
Code effective date: 20220401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF